Latest News
The Kempen European Private Equity Fund has acquired a significant direct interest in Wilvo Group a family business in the province of Brabant in the Netherlands that specialises in the processing of thin sheet metal and precision parts assembly.
Wilvo Group employs 230 people and has an annual turnover of approximately EUR50 million.
The participation of the Kempen European Private Equity Fund is a co-investment with the German investment company Steadfast Capital. The investors have backed the management buy-out by the Wilvo management team, who, as new co-owners, are highly motivated to drive further growth for Wilvo Group, both
Private equity manager Keensight Capital has acquired Infarco’s majority stake in 3P Biopharmaceuticals, a Contract Development and Manufacturing Organisation (CDMO) specialised in the process development and GMP manufacturing of biologics.
Founded in 2006 and based near Pamplona, Spain, 3P Biopharmaceuticals offers a complete biologics production service, from preclinical and clinical stages, all the way to full-scale commercial manufacturing.
3P provides a comprehensive service which is focused on quality, flexibility and a strong, two-way partnership with its clients.
With more than 240 employees and a wide number of customers located in Europe, North America, Australia and Asia, 3P Biopharmaceuticals has successfully
CEE private equity firm Innova Capital is to acquire Optiplaza, one of the major players in the Romanian optical market. The transaction marks further stronger entry of the fund into the attractive and growing optical market.
The funds managed by Innova Capital have signed an agreement to acquire 100 per cent of shares in Optiplaza. This is the second transaction by Innova Capital in the optical space in Romania this year. Both transactions are currently being assessed by the Competition Council and will be implemented following their clearance by the competition authority.
Optiplaza was set up in 2004 and
DW Healthcare Partners, a private equity firm focused primarily on making control investments in North American middle market healthcare companies, has closed its fifth fund.
The fund was oversubscribed and met its cap of USD610 million in total capital commitments. This brings DW Healthcare Partners’ total capital under management to USD1.43 billion.
“We are grateful for the support we have received from both previous and new investors in Fund V. We believe we have earned their trust through our long track record, sourcing model, and differentiated investment strategy,” says DW Healthcare Partners’ Co-Founder and Managing Partner, Andrew Carragher.
DW Healthcare
Duff & Phelps has appointed Jacco Brouwer as leader of its European Debt Advisory practice, further strengthening its debt advisory and restructuring offerings.
Brouwer joins Duff & Phelps from global business advisory firm AlixPartners, where he served as head of debt advisory, and brings to the firm more than 27 years of experience in banking and finance with significant expertise advising private equity and corporate clients on debt raisings and refinancings. He is focused on leveraged buyout loans, growth and acquisition finance and asset-backed loans.
Prior to AlixPartners, he was one of the co-founding partners at Versatus Advisers, a London-based debt advisory and
Venture capital funds globally reached their best post-2009 crisis period performance in Q4 2018, surpassing the previous best recorded one year earlier, according to eFront’s latest Quarterly Private Equity Performance report.
Performance of VC funds globally reached 1.531x in Q4 2018 – the highest level on record – before dipping back below 1.5x in the first quarter of this year.
2018 was the best ever year for VC performance, with high returns associated with low risk and shorter time-to-liquidity, as VC funds capitalised on a favourable exit environment.
Return dispersion in 2019 remains below the level seen in 2014 to
Sidley Austin has appointed Oren Gertner as a partner in the firm’s premier Investment Funds practic in New York. Gertner joins from Davis Polk & Wardwell LLP, where he was in the firm’s Corporate department, practicing in the Investment Management group.
“Over the past two years, Sidley has prioritised the growth and development of our private equity funds and other illiquid private funds capabilities, particularly within international money centres like New York,” says William D Kerr, global leader of Sidley’s Investment Funds practice and a member of the firm’s Executive Committee. “The arrival of Oren, who is an exemplary talent
By Elizabeth Pfeuti – Co-investments remain a theme in 2019, as both GPs and LPs increasingly see value in separate partnerships alongside commingled funds.
Earlier this year, the listed Standard Life Private Equity Trust announced it would allocate up to 20 per cent of its net asset value to these partnerships, kicking off with a stake in Midlands-based Mademoiselle Desserts alongside Europe-focused IK Investment Partners.
Institutional investors, too, such as pension and sovereign wealth funds, are getting in on the act. Some of the largest public pensions in the US, including the Teacher Retirement System of Texas, which announced this year
Vistra, a global trust, fund administration and corporate services provider, has launched its Economic Substance Services and Solutions, starting with the British Virgin Islands (BVI) Economic Substance Classification Questionnaire designed to help clients determine the classification of their BVI company as it applies to the substance legislation.
Developed by Vistra’s in-house legal team, the BVI Economic Substance Classification Questionnaire is an efficient and effective service for any BVI entity to gain clarity on their status, supported by detailed analysis and tailored solutions.
Simon Filmer, Global Lead, Company Formation, Vistra, says: “It is now mandatory for all BVI entities to comply
Tortoise has named Senior Managing Director Michelle Kelly Johnston as Chief Financial Officer (CFO).
Johnston, a member of Tortoise’s Executive Committee, will be responsible for business strategy & management, corporate finance (including capital allocation, M&A execution and financing), financial planning & analysis and financial reporting.
“We are delighted that Michelle has taken the CFO role to lead an important area of our business including strategic capital prioritisation and allocation for business decisions and growth initiatives,” says Tortoise Chief Executive Officer, Kevin Birzer. “Michelle’s strategic strengths, leadership across the firm and her business and financial acumen make her ideal for
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
